Challenge
Organizations often grow their Quality Management Systems in silos — different rules, templates, and approval chains for each business line or product category. This complexity increases compliance risk, slows decision-making, and creates inefficiencies, especially in diversified product portfolios like pharmaceuticals, OTC medicines, cosmetics, and food supplements.
Our Experience & Approach
We have led QMS design and harmonization projects at both start-up and global Big Pharma level, addressing the full product lifecycle from R&D through to market. This included:
- Establishing a compliant, fit-for-purpose QMS for a newly acquired start-up to enable scale-up without disrupting agility.
- Global harmonization of supplier selection, qualification, and management processes across multiple product categories — including OTC, APIs, raw materials, cosmetics, and food supplements — ensuring one seamless standard from R&D to commercial launch.
- Audit management integration, aligning systems to meet EU, FDA, and other global GxP/ISO frameworks while eliminating redundant steps and documents.
We applied a what–why–how methodology:
- What is truly needed to meet compliance requirements and support operational needs.
- Why each element adds value — challenging legacy “because we’ve always done it” approaches.
- How to implement it efficiently, embedding controls and documentation flows that follow the product through its entire lifecycle.
Impact
The harmonized QMS not only reduced complexity and improved audit readiness, it also brought supplier assessments into earlier stages of the product lifecycle. This allowed organizations to select the right suppliers faster, reduce qualification timelines, and avoid late-stage surprises that can delay launches. As a result, faster onboarding, smoother launch, and a stronger ability to maintain supply continuity were achieved.